cladribine has been researched along with Enlarged Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bányai, A; Gopcsa, L; Karádi, A; Matolcsy, A; Pálóczi, K; Tamáska, J | 1 |
| Faoro, LN; Mesa, RA; Tefferi, A | 1 |
| Li, CY; Silverstein, MN; Tefferi, A | 1 |
3 other study(ies) available for cladribine and Enlarged Liver
| Article | Year |
|---|---|
Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Topics: Adult; Antineoplastic Agents; Cladribine; Female; Hepatomegaly; Humans; Lymphoma, T-Cell; Receptors, Antigen, T-Cell, gamma-delta; Recurrence; Remission Induction; Splenomegaly | 2002 |
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Topics: Adult; Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Hematologic Diseases; Hepatomegaly; Humans; Male; Middle Aged; Palliative Care; Primary Myelofibrosis; Retrospective Studies; Splenectomy | 2005 |
2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.
Topics: Anemia; Cladribine; Female; Follow-Up Studies; Hepatomegaly; Humans; Leukocytosis; Male; Primary Myelofibrosis; Splenectomy; Thrombocytosis; Treatment Outcome | 1997 |